Home Online Features LogiCare3PL Supports Commercial Launch of Soleno Therapeutics' VYKAT XR Following FDA Approval
LogiCare3PL Supports Commercial Launch of Soleno Therapeutics’ VYKAT XR Following FDA Approval
Hand-out
Press Releases
BioCare  
April 28, 2025

LogiCare3PL Supports Commercial Launch of Soleno Therapeutics’ VYKAT XR Following FDA Approval

First and only FDA-approved treatment for hyperphagia in Prader-Willi syndrome reaches patients through LogiCare3PL's specialty pharmaceutical logistics platform

avatar profile Olean Times Herald

Olean Times Herald

email Olean Times Herald

Local & Social